Phase II study of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non‐small cell lung cancer

BACKGROUND: Cisplatin (CDDP) and vinorelbine as an adjuvant chemotherapy improve the overall survival of patients with completely resected non‐small cell lung cancer (NSCLC). However, the treatment completion rate is low due to severe adverse events (AEs). Pemetrexed (PEM) has been used in advanced...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Tachihara, Motoko, Dokuni, Ryota, Okuno, Keiko, Tokunaga, Shuntaro, Nakata, Kyosuke, Katsurada, Naoko, Yamamoto, Masatsugu, Nagano, Tatsuya, Kobayashi, Kazuyuki, Tanaka, Yugo, Funada, Yasuhiro, Maniwa, Yoshimasa, Nishimura, Yoshihiro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471012/
https://ncbi.nlm.nih.gov/pubmed/32729237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13567
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados